RACHEL HOLLAND: Open Payments
NPI 1225755143 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 24 payments from 11 companies in 2025. Trend: 2023 $700 · 2024 $700 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 7 | $125 |
| Amgen Inc. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $25 |
| ABIOMED | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
Products named: FUROSCIX, REPATHA, CAMZYOS, FARXIGA, LifeVest, WAINUA, CARDIOMEMS, NEXLETOL.
Industry payments across MO — which companies pay providers there.
